letrozole / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 114 Diseases   361 Trials   361 Trials   7200 News 


«12...8384858687888990919293...100101»
  • ||||||||||  Piqray (alpelisib) / Novartis, Kisqali (ribociclib) / Novartis
    Enrollment change, Metastases:  CLEE011X2107: Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (clinicaltrials.gov) -  Mar 30, 2017   
    P1,  N=225, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2017 --> Sep 2017 N=300 --> 225
  • ||||||||||  samotolisib (LY3023414) / Eli Lilly
    Trial primary completion date, Metastases:  A Study of LY3023414 in Participants With Advanced Cancer (clinicaltrials.gov) -  Mar 21, 2017   
    P1,  N=130, Recruiting, 
    Trial primary completion date: Nov 2016 --> Nov 2017 Trial primary completion date: Jul 2017 --> Mar 2018
  • ||||||||||  letrozole / Generic mfg.
    Enrollment closed, Enrollment change, Trial initiation date:  Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment (clinicaltrials.gov) -  Mar 21, 2017   
    P2/3,  N=35, Active, not recruiting, 
    Trial primary completion date: Jul 2017 --> Mar 2018 Recruiting --> Active, not recruiting | N=50 --> 35 | Initiation date: Feb 2013 --> Oct 2013
  • ||||||||||  letrozole / Generic mfg., exemestane / Generic mfg.
    Trial completion, Trial primary completion date, Metastases:  Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer (clinicaltrials.gov) -  Mar 14, 2017   
    P2,  N=60, Completed, 
    Trial primary completion date: Aug 2017 --> Dec 2017 Trial primary completion date: Jun 2017 --> Jul 2014 | Active, not recruiting --> Completed
  • ||||||||||  letrozole / Generic mfg., everolimus / Generic mfg.
    Trial primary completion date, Metastases:  Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer (clinicaltrials.gov) -  Feb 23, 2017   
    P2,  N=42, Active, not recruiting, 
    Initiation date: Dec 2015 --> Jun 2016 | Trial primary completion date: May 2019 --> Sep 2019 Trial primary completion date: Apr 2017 --> Apr 2018
  • ||||||||||  Ibrance (palbociclib) / Pfizer
    Enrollment closed:  Palbociclib and FES PET (clinicaltrials.gov) -  Feb 15, 2017   
    P2,  N=15, Active, not recruiting, 
    Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
  • ||||||||||  Torisel (temsirolimus) / Pfizer
    Trial completion, Combination therapy, Metastases:  Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms (clinicaltrials.gov) -  Feb 6, 2017   
    P2,  N=108, Completed, 
    Recruiting --> Active, not recruiting Terminated --> Completed
  • ||||||||||  letrozole / Generic mfg.
    Trial completion, Trial primary completion date:  Letrozole Pretreatment With Misoprostol for Second-Trimester Medical Abortion (clinicaltrials.gov) -  Jan 26, 2017   
    P2/3,  N=400, Completed, 
    Trial primary completion date: Jul 2016 --> Dec 2017 Recruiting --> Completed | Trial primary completion date: Aug 2016 --> Dec 2016
  • ||||||||||  letrozole / Generic mfg., sorafenib / Generic mfg.
    Trial primary completion date, Metastases:  Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer (clinicaltrials.gov) -  Jan 24, 2017   
    P1/2,  N=54, Active, not recruiting, 
    Initiation date: Nov 2016 --> Feb 2017 | Trial primary completion date: Apr 2019 --> Jul 2019 Trial primary completion date: May 2017 --> May 2018
  • ||||||||||  letrozole / Generic mfg.
    Enrollment closed, Trial primary completion date:  PLUM: Pilot of Letrozole for Uterine Myomas (clinicaltrials.gov) -  Jan 17, 2017   
    P4,  N=20, Active, not recruiting, 
    Trial primary completion date: May 2017 --> May 2018 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  hydrocortisone / Generic mfg., flutamide / Generic mfg.
    Trial completion, Trial completion date, Combination therapy:  Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia (clinicaltrials.gov) -  Jan 13, 2017   
    P1,  N=62, Completed, 
    Trial primary completion date: Dec 2016 --> Mar 2017 Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Jan 2017
  • ||||||||||  Piqray (alpelisib) / Novartis, Kisqali (ribociclib) / Novartis
    Trial primary completion date, Metastases:  CLEE011X2107: Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer (clinicaltrials.gov) -  Jan 11, 2017   
    P1,  N=300, Recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2017 --> Jan 2017 Trial primary completion date: Dec 2018 --> Dec 2019